PolyNovo Announces Breast Device Development Agreement
Filed with ASX · · 2 pages · English
Watch Polynovo's latest callPolynovo (ASX:PNV) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Polynovo (ASX:PNV) Q4 2026 Earnings CallEarlier from Polynovo
- PolyNovo signs MOU for global breast partnership
- New Sales and Repeat Orders in the US
- PolyNovos Israel Market Entry
- Placement and Share Purchase Plan
- Further US Sales for NovoSorb BTM
Later from Polynovo
- Results announcement, App 4D and Half-Year Financial Report
- PolyNovo Announces Breast Device Development Program
- Final patient enrolled in CE Mark Burn Trial
- NovoSorb BTM approved for sale in Saudi Arabia
- Final Patient enrolled in BARDA Feasibility Burn Trial
Follow Polynovo into a list and get an email when it puts out news.
Follow Polynovo